Figure 4b: Genes regulated   2-fold in TF1.8 cells 8 h after IL-5 withdrawal  relative to
the 8-h control cells exposed to IL-5

Figure 2: The genes whose expression changed by more than 2-fold after
addition of IL-5 to eosinophils

Supplementary Table 1. Dataset for Gene Expression

SuppTable 1. Relatively underexpressed genes in MLL as compared to ALL

SuppTable 2. Relatively overexpressed genes in MLL compared to ALL

Figure 2. Identification of genes differentially expressed in M- and UM-CLLs

Figure 5. (A and B) Response of CLL subtype distinction genes during B cell activation.

Table 4. Genes downregulated in the intestine of C57B1/6J mice fed Se-deficient (<0.01 mg/kg) diet

Table 3. Genes upregulated in the intestine of C57B1/6J mice fed Se-deficient (<0.01 mg/kg) diet

Table 4: Frequency of LOH in endometrial hyperplasia and cancer specimensa

Fig. 3. Hierarchical clustering dendrogram and gene expression data from GISTs and spindle cell tumors.

Table1b. Genes differentially expressed in two subtypes of DLBCL: Most unique for DLBCL  ABL subtype

Table 2.   A List of ESTs That Were Found to be Differentially Expressed Based on Their Range of Numeric Expression Value and At Least a Threefold Difference in Expression Between NOV-31 and Any EOC Cell Line

Table 3. Comparison of Array-Derived and Real-Time PCR Measured Ratios of Gene Expression in Hypoxic versus Normoxic Vessels

70 good and poor prognostic marker genes (mammaprint) extracted from Figure 2

231 probesets. Poor Prognosis Signature. A gene expression signature predictive of a short interval to distant metastases ('poor prognosis' signature) in patients without tumour cells in local lymph nodes at diagnosis (lymph node negative (The 70 gene Mam

2460 probesets.  Genes that co-regulate with the ER- alpha gene (/ESR1)/.

430 probesets.  Signature that identifies tumours of BRCA1 carriers

TABLE I Genes in which expression was altered more than 2-fold

Table 6. Genes with “spiked” expression in subsets of MM PCs from newly diagnosed patients